Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $139 | $69 | $24 | $14 |
| Short-Term Investments | $295 | $193 | $181 | $273 |
| Receivables | $2 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $4 | $4 | $3 |
| Total Curr. Assets | $438 | $267 | $209 | $291 |
| Property Plant & Equip (Net) | $2 | $3 | $4 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $7 | $3 | $1 |
| Total NC Assets | $13 | $10 | $7 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $451 | $277 | $216 | $296 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $0 | $0 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $36 | $18 | $15 | $8 |
| Total Curr. Liab. | $42 | $22 | $17 | $9 |
| LT Debt | $0 | $1 | $2 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $1 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $3 | $3 |
| Total Liabilities | $42 | $23 | $18 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$435 | -$306 | -$209 | -$104 |
| AOCI | $0 | $0 | -$2 | -$0 |
| Other Equity | $844 | $559 | $408 | $389 |
| Total Equity | $409 | $254 | $198 | $285 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $451 | $277 | $216 | $296 |
| Net Debt | -$138 | -$66 | -$21 | -$11 |